JPRN-UMIN000008597招募中未知
Impact of azilsartan on proteinuria in patients with chronic kidney disease - Impact of azilsartan on proteinuria
Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 160 人开始时间: 2012年8月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Pregnancy 2. History of hypersensitivity to azilsartan or candesartan 3. Myocardial infarction or stroke in the past 6 months 4. Potassium >= 5.5 mEq/L 5. During lactating 6. Liver dysfunction (ALT > 3-times the upper limit of normal) 7. IgA nephropathy starting steroid therapy within 1 year 8. Known bilateral renal artery stenosis 9. Severe nephrotic syndrome (serum alb < 2g/dL) 10. Active cancer 11. Severe infection 12. Judged as inappropriate for the study
研究者
相似试验
已完成
不适用
Trial of Proteinuria Reduction Effect of Losartan/Hydrochlorothiazide Therapy to Chronic Kidney Disease with HypertensioChronic kidney disease patients with hypertensionJPRN-UMIN000001643Kyushu University Hospital Kidney Care Unit120
已完成
4 期
Effects of azilsartan in chronik kidney disease with hypertensiochronick kidney disease with hypertensionJPRN-UMIN000010788Division of Nephrology, Department of Internal medicine, Jichi Medical University30
已完成
4 期
Medical effects of Azilsartan in patients with hypertension not controlled by other ARBshypertensionJPRN-UMIN000010610ishi Mikawa Cardiologist Conference400
已完成
3 期
Effect of sitagliptine on proteinuriaDiabetic nephropathy.Type 2 diabetes mellitus with diabetic nephropathyE11.21IRCT20201028049174N1Esfahan University of Medical Sciences90
已完成
不适用
Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.Type 2 diabetes mellitus with hypertensionJPRN-UMIN000010604Iwasaki Naika Clinic20